Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA02 - Molecular Underpinnings of Lung Cancer Histological Differentiation and Targeted Therapeutics
- 10:45 - 11:45
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Erik Thunnissen, Rafael Rosell
-
+
MA02.06 - Discussant
11:02 - 11:12 | Presenter: Yuko Minami
- Abstract
Loading...
-
+
ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance
- 12:00 - 13:00
- 8/07/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Tumor Biology and Biomarkers
- Moderators:Benjamin Besse, Yuko Minami
-
+
Session Moderator
12:50 - 13:00 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
Session Moderator
12:50 - 13:00 | Presenter: Yuko Minami
- Abstract
Loading... -
+
ES07.01 - Session Introduction
12:00 - 12:01 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
ES07.02 - Session Introduction
12:01 - 12:02 | Presenter: Yuko Minami
- Abstract
Loading... -
+
ES07.03 - NSCLC Persister Cells and Their Role in Treatment Resistance and Disease Progression
12:02 - 12:14 | Presenter: Trever Bivona
- Abstract
Loading... -
+
ES07.04 - Biological Role and Actionability of Molecular/Immune Alterations after Acquired Resistance to Single-Agent and Combination Therapies (Focus on EMT, Includes SCLC)
12:14 - 12:26 | Presenter: Sandra Ortiz-Cuaran
- Abstract
Loading... -
+
ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC
12:26 - 12:38 | Presenter: Triparna Sen
- Abstract
Loading... -
+
ES07.06 - Biological Advances in SCLC: Molecular Subtypes, Anti-tumor Immune Responses and Impact on Therapeutics
12:38 - 12:50 | Presenter: Helmut Popper
- Abstract
Loading... -
+
ES07.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
MA12 - Pathology: Tumour Diagnostics
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Pathology
- Moderators:Aleks Ryska, Deepali Jain
-
+
MA12.07 - Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma With Lepidic Growth
11:12 - 11:17 | Presenter: Erik Thunnissen
- Abstract
Loading...